13/11/2025
You don’t need shortage notifications – you need supply alerts.
Official notices confirm a problem that has already started. To protect your supply chain, you need to see the first signals of disruption.
Consider the current landscape for critical Parkinson's disease medicines in the UK. Our platform reveals a pattern of escalating risk that proactive teams can act on now:
• Levodopa + Carbidopa (Co-Careldopa/Sinemet): 94 supply alerts in the last 12 months (38 in the last 90 days). Sinemet 10/100 mg tablets are facing supply issues until the end of November 2025.
• Pramipexole (Mirapexin/generics): 297 supply alerts in 12 months (97 in the last 90 days). Supply issues for multiple lines, including Mirapexin tablets, are projected to last until March 2026.
• Ropinirole (Requip XL/generics): 213 supply alerts in 12 months (72 in the last 90 days). Key products like Repinex XL 8 mg tablets face supply disruption until April 2026.
While the definition of a "shortage" can be debated, these alerts provide what procurement and supply chain teams truly need: a chance to get ahead.
Stop waiting for lagging notifications. Start acting on real-time intelligence for the products that matter to your business.
Contact us to book a demonstration and see how our platform can give you a critical head start.